We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

41 hedge funds and large institutions have $74.3M invested in VanEck Pharmaceutical ETF in 2013 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

31.2% more ownership

Funds ownership: 0% → 31.2% (+31%)

Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.34%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
41
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
JWM
26
Jacobus Wealth Management
Wisconsin
$253K +$257K +5,560 New
SB
27
Suntrust Banks
Georgia
$251K +$256K +5,544 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$227K +$231K +5,000 New
KFC
29
Klingenstein Fields & Co
New York
$218K +$222K +4,800 New
Wells Fargo
30
Wells Fargo
California
$218K +$222K +4,800 New
LPL Financial
31
LPL Financial
California
$213K +$217K +4,689 New
AWM
32
Altavista Wealth Management
North Carolina
$200K +$203K +4,400 New
OPCM
33
Osborne Partners Capital Management
California
$200K +$203K +4,400 New
PNC Financial Services Group
34
PNC Financial Services Group
Pennsylvania
$94K +$95.8K +2,072 New
DADC
35
D.A. Davidson & Co
Montana
$69K +$70.5K +1,525 New
GT
36
Glenmede Trust
Pennsylvania
$45K +$46.2K +1,000 New
Deutsche Bank
37
Deutsche Bank
Germany
$26K +$26.8K +580 New
HCM
38
Highlander Capital Management
New Jersey
$22.7K +$23.1K +500 New
LTFS
39
Ladenburg Thalmann Financial Services
Florida
$18K +$18.5K +400 New
Ameriprise
40
Ameriprise
Minnesota
$5K +$4.62K +100 New
Citigroup
41
Citigroup
New York
$5K +$4.76K +103 New
1
2

PPH Hedge Fund Activity: Q2 2013 in Review

41 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q2 2013, worth a combined $74.3M.

Buyers outnumbered sellers: 41 funds opened new PPH positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

  • 41 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $74.3M of VanEck Pharmaceutical ETF stock for Q2 2013.
  • 41 funds opened new VanEck Pharmaceutical ETF positions in Q2 2013 and 0 closed out, a net change of +41 holders.

Based on aggregated 13F filings for Q2 2013.